Representing a more than $100 million investment, the plant will primarily support the British medtech giant’s orthopedics business, which the company expects to grow strongly in the Asia-Pacific region.
S+N expects the facility — located at the Batu Kawan Industrial Park in Malaysia’s northwest state of Penang — to create 800 local jobs in manufacturing, engineering and supply chain in the coming years.
“We are thrilled to open this new manufacturing facility in Malaysia which represents our commitment to Asia-Pacific, Malaysia, our customers and their patients. It is also a critical piece of our Strategy for Growth, improving efficiency and resilience, and supports our purpose of Life Unlimited so that patients across the region and beyond can return to living life to their fullest,” Smith+Nephew CEO Dr. Deepak Nath said in a June 28 news release.
Penang officials boast that the area has become a medical devices hub in the region, with a high concentration of medtech jobs.
